Knowledge Center
Article / Feb 01, 2015
The Time Has Come
Source:
PMPS, 2015, February, pp. 30 - 33
The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
Related links
Also in the Knowledge Center
/ Oct 13, 2021
Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry
Read more
Scientific Article
/ Oct 18, 2021
Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release
Read more
Scientific Article
/ Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Read more
Scientific Article